Medicenna Therapeutics Stock Quote MDNA - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.157

Bid

0.1565

Ask

0.1612

Volume

0.00 Day's Range 0.00

0.151251 52 Week Range 0.316

Market Cap

10.933M

Previous Close

0.157

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

69,637,000

Dividend Yield

PE Ratio

-5.52

Earnings Per Share (EPS)

-0.37

Revenue

Net Profit

-25.47M

Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically ... Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.medicenna.com

Headquarters

Toronto, Ontario, Can

Founded

Medicenna Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MDNA. The last closing price for Medicenna Therapeutics was $0.16. Over the last year, Medicenna Therapeutics shares have traded in a share price range of $ 0.151251 to $ 0.316.

Medicenna Therapeutics currently has 69,637,000 shares outstanding. The market capitalization of Medicenna Therapeutics is $10.93 million. Medicenna Therapeutics has a price to earnings ratio (PE ratio) of -5.52.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.157	0.157	0.157	0	0	CS
4	0	0	0.157	0.157	0.157	0	0	CS
12	0	0	0.157	0.157	0.157	0	0	CS
26	0	0	0.157	0.157	0.157	0	0	CS
52	-0.1399	-47.1202425059	0.2969	0.316	0.151251	32594	0.22543159	CS
156	-2.323	-93.6693548387	2.48	2.94	0.151251	118977	0.94715487	CS
260	-4.473	-96.6090712743	4.63	6.84	0.151251	126110	1.80496231	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ZEOZeo Energy Corporation	$ 2.4901 (118.43%)	58.03M
GSIWGarden Stage Ltd	$ 4.79 (111.01%)	50.71M
TBIOTelesis Bio Inc	$ 2.51 (84.56%)	51.5M
XCURExicure Inc	$ 3.86 (68.56%)	16.7M
NCINeo Concept International Group Holdings Ltd	$ 0.7543 (53.94%)	2.43M
HAOHaoxi Health Technology Ltd	$ 0.7701 (-74.33%)	7.23M
XCHXCHG Ltd	$ 11.5008 (-37.39%)	1.26M
HOVRNew Horizon Aircraft Ltd	$ 0.4899 (-33.89%)	2.94M
PGNYProgyny Inc	$ 16.515 (-32.43%)	13.81M
GDHGGolden Heaven Group Holdings Ltd	$ 2.94 (-29.50%)	513.55k
NVDANVIDIA Corporation	$ 119.0117 (4.98%)	202.06M
SQQQProShares UltraPro Short QQQ	$ 7.685 (-8.51%)	172.55M
HOLOMicroCloud Hologram Inc	$ 0.2336 (15.47%)	104.61M
MAXNMaxeon Solar Technologies Ltd	$ 0.1011 (11.22%)	93.27M
FRGTFreight Technologies Inc	$ 0.1222 (-1.37%)	80.6M